Skip to main content
. 2019 May 27;18(2):1049–1056. doi: 10.3892/ol.2019.10406

Figure 2.

Figure 2.

MYH9 overexpression was associated with disease progression free and overall survival in ovarian cancer patients. MYH9, myosin 9.